The Greyfield Infusion Report 2026

What public Medicare data shows about where infusion is growing: what Medicare pays doctors and clinics for infusion drugs in every state, the therapies behind it, and how much demand each registered infusion center serves. Written for infusion owners and operators deciding where to grow. It uses the 2024 Medicare claims CMS released in May 2026, the most recent available.

Cover of The Greyfield Infusion Report 2026, with an infusion suite photo, built on the latest Medicare data released May 2026, showing $6.0B in Medicare infusion drug payments, up 19% since 2022, and 1,806 infusion centers

Get the white paper

PDF, 10 pages, 203 KB

Your details go to Linus Tse at Greyfield Data, who may follow up about the paper. See the privacy policy.

What's inside

Spending up, infusions down

Medicare infusion drug payments grew 19% from 2022 to 2024 while infusion services fell 5%, so each infusion now carries more drug spending.

Where demand is growing, and the biggest markets

Growth by state for the 29 states with at least $50M in 2022, and the 18 largest markets with their providers, infusion centers and open nursing jobs.

Demand per infusion center

Medicare infusion drug payments per registered infusion center in each state, from more than $10M in Iowa and Nebraska to about $1M in Colorado.

Therapies and who gives infusions

The ten largest Part B infusion drugs and their growth since 2022, and which specialties bill office infusions, from oncology to nurse practitioners.

Contents

  1. The short versionpage 2
  2. Spending up, infusions downpage 3
  3. Where demand is growingpage 4
  4. The biggest marketspage 5
  5. Demand per infusion centerpage 6
  6. How fast centers are openingpage 7
  7. The therapies behind the growthpage 8
  8. Who gives infusionspage 9
  9. Reading this for your own marketpage 10

Charts From the Report

Change since 2022: Medicare infusion drug payments 19%, infusion services -5%. Drug payments per infusion went from $372 to $469.
Spending is up. Infusions are down.Download PNG
Infusion centers registered per year, 2008 to 2026: about 38 a year in 2013 to 2015, about 161 a year in 2023 to 2025. 2026 is a partial year.
Infusion centers are opening 4x faster than a decade agoDownload PNG
Growth in Medicare infusion drug payments, 2022 to 2024: Kansas 38%, California 33%, Pennsylvania 32%, Minnesota 27%, Iowa 27%, Texas 26%, Colorado 25%, Arizona 24%, Maryland 23%, Oklahoma 23%, United States 19%.
Kansas, California and Pennsylvania grew fastestDownload PNG
Medicare infusion drug payments per registered infusion center, 2024: Iowa $10.8M, Nebraska $10.4M, Delaware $9.1M, Arkansas $8.8M, Kansas $7.9M, Pennsylvania $7.6M, Oregon $6.8M, Illinois $6.6M, United States $3.3M, Michigan $1.6M, Utah $1.4M, Colorado $1.2M.
Iowa and Nebraska have 3x the demand per centerDownload PNG